Varenicline for quitting smoking in people with schizophrenia
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether varenicline helps people with schizophrenia or schizoaffective disorder stop smoking. It also looks at related nervous-system side effects that can happen with some anti-psychotic medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of schizophrenia or schizoaffective disorder and your condition is stable
- You have a qualifying history of tardive dyskinesia (involuntary movement problem)
- You smoke at least 5 cigarettes per day for at least 30 days, and your breath test shows carbon monoxide > 5 ppm
- You agree to stop smoking about 4 weeks after the study starts
- You can get approval from your mental health clinician for varenicline (especially if you already see one)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining brain stimulation (tDCS) with a smoking cessation medication (varenicline) helps people quit smoking. You would attend daily visits for two weeks.
This study tests whether a medication called varenicline (often used to help people stop smoking) can help reduce cannabis use in people with cannabis use disorder. If you qualify, you'll receive the medication or a placebo and be followed to see how it affects your cannabis use.
This Phase 3 trial tests a quit-smoking program using varenicline (a medicine) plus additional support, for people with HIV who currently use tobacco. It may help you stop smoking or using tobacco and stay quit with safer, guided care.
This trial tests if varenicline, a stop-smoking medication, can help people ages 18 to 40 quit e-cigarettes while also using cannabis. It's designed for regular e-cigarette users who want to quit and who use cannabis at least 10 days per month.
This study tests whether a medication called varenicline (or a placebo) can help people who use both tobacco and cannabis to quit or cut back. It takes place in South Carolina and lasts 12 weeks.
This study tests whether using two quit-smoking medicines together helps people stop both cigarettes and vaping. It may offer extra support to help you quit.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.